We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].
Taking action by sending messages to your Congressional delegation makes a difference, and our online campaigns make it easy to do. Don't take it from us, hear from Rosa DeLauro, Ranking Member of the House Appropriations Committee, why your voice matters.
The administration has abruptly cancelled all National Institutes of Health (NIH) funding for the Diabetes Prevention Program. The loss of this ongoing research, which is being conducted at 30 institutions in 21 states, will impact tens of millions of people who have Type 2 diabetes and prediabetes nationwide. This program has followed thousands of participants since its creation in 1996 and has provided an important source of long-term information on diabetes prevention. Every Senator and Representative needs to hear from their constituents that it is critical this program is restored immediately.
Since January, there have been multiple actions to cut federal funding of research including attempts to freeze all grants and limit indirect costs for NIH grants to 15%. These efforts have caused major harm to institution budgets, jeopardized lifesaving medical research, caused layoffs, suspended clinical trials, and disrupted ongoing research and laboratory support programs. While federal judges have blocked these actions at least temporarily, we are concerned there will be further efforts to cut federal funding of research. Endocrine Society members are encouraged to join our campaign to share with your US Representative and Senators how cutting federal funding for your research would impact your work.
We need Congress to protect funding for the National Institutes of Health (NIH) in 2025 and provide adequate funding levels for NIH in Fiscal Year 2026. This will affect all researchers who receive grant funding from NIH. Funding for the NIH is in danger: funds appropriated for research by Congress are not being released, the NIH is developing major restructuring plans without transparency, and the President's budget for FY26 proposes a 40% cut to NIH. Currently, delays and disruptions to grant review persist; many researchers are unable to draw down funds, and over $2 billion in grants have been cancelled outright. We are urging Congress to protect the NIH now and provide the NIH with at least $51.303 billion in the next fiscal year. It is imperative that all Senators and Representatives hear from their constituents about the importance of funding NIH. Many congressional offices are not aware this is affecting their states.
Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.
